Abstract
Objectives: Phosphodiesterase III inhibitors, which have both positive inotropic and vasodilatory effects, occasionally cause hypotension due to afterload reduction and possibly due to preload reduction caused by the increase in vascular capacitance.Methods: Six open-chest adult mongrel dogs were used to compare the effects on left ventricular contractility, afterload, and vascular capacitance of the phosphodiesterase III inhibitor, olprinone, with those of dobutamine using a right-heart-bypass model. Contractility and afterload were evaluated by the left ventricular pressure-volume relations with the use of a conductance catheter to derive the end-systolic elastance (Ees) and the effective arterial elastance (Ea). Vascular capacitance change was evaluated by reservoir volume change under a constant bypass flow (80 ml/kg per minute).Results: Ees increased significantly both with dobutamine (7.6±2.8 to 14.3±4.8 mmHg/ml, p<0.05) and with olprinone (7.6±2.9 to 11.5±4.2 mmHg/ml, p<0.05). Ea did not change with dobutamine (14.4±3.5 to 14.5±3.6 mmHg/ml, p=0.9), whereas it decreased with olprinone (14.0±4.1 to 11.4±3.8 mmHg/ml, p=0.093). Reservoir volume increased after the infusion of dobutamine (−94.0±39.8 ml), and decreased after the infusion of olprinone (−114.0±62.3 ml). The difference was statistically significant (p=0.007). The reservoir volume change indicated that vascular capacitance decreased with dobutamine, and increased with olprinone.Conclusions: Pre- and afterload reduction of olprinone combined with the positive inotropic effect are useful in treating congestive heart failure and managing low cardiac output syndrome after cardiac surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Konstam MA, Cody RJ. Short-term use of intravenous milrinone for heart failure. Am J Cardiol 1995; 75: 822–6.
Colucci WS. Positive inotropic/vasodilator agents. Cardiol Clin 1989; 7: 131–44.
Chon JN, Franciosa JA. Vasodilator therapy of cardiac failure. N Engl J Med 1977; 297: 27–31.
Takaoka H, Takeuchi M, Odake M, Hayashi Y, Mori M, Hata K, et al. Comparison of the effects on ventriculoarterial coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J Am Coll Cardiol 1993; 22: 598–606.
Tanoue Y, Morita S, Ochiai Y, Hisahara M, Masuda M, Kawachi Y, et al. Inhibition of lipid peroxidation with the Lazaroid U74500A attenuates ischemia-reperfusion injury in a canine orthotopic heart transplantation model. J Thorac Cardiovasc Surg 1996; 112: 1017–26.
Tanoue Y, Morita S, Hisahara M, Tominaga R, Kawachi Y, Yasui H. Arresting donor hearts with extracellular-type cardioplegia prevents vasoconstriction induced by UW solution. Cardiovasc Surg 1998; 6: 622–8.
Tanoue Y, Morita S, Ochiai Y, Haraguchi N, Tominaga R, Kawachi Y, et al. Nitroglycerin as a nitric oxide donor accelerates lipid peroxidation but preserves ventricular function in a canine orthotopic heart trans-plantation model. J Thorac Cardiovasc Surg 1999; 118: 547–56.
Tanoue Y, Sese A, Ueno Y, Joh K, Hijii T. Bidirectional Glenn procedure improves the mechanical efficiency of a total cavopulmonary connection in hig-risk Fontan candidates. Circulation 2001; 103: 2176–80.
Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70: 812–23.
Shigemi K, Brunner MJ, Shoukas AA. α- and β-Adrenergic mechanisms in the control of vascular capacitance by the carotid sinus baroreflex system. Am J Physiol 1994; 267: H201–10.
Suga H. Ventricular energetics. Physiol Rev 1990; 70: 247–77.
Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985; 71: 994–1009.
Little WC. The left ventricular dP/dtmax-end-diastolic volume relation in closed-chest dogs. Circ Res 1985; 56: 808–15.
Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 245: H773–80.
Nozawa T, Yasumura Y, Futaki S, Tanaka N, Uenishi M, Suga T. Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation. 1988; 77: 1116–24.
Goenen M, Pedemonte O, Baele P, Col J. Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 1985; 56: 33B-8B.
Kass DA, Grayson R, Marino P. Pressure-volume analysis as a method for quantifying simultaneous drug (amrinone) effects on arterial load and contractile state in vivo. J Am Coll Cardiol 1990; 16: 726–32.
Feneck RO. The European Milrinone Multicentre Trial Group. Intravenous milrinone following cardiac surgery. J Cardiothorac Vasc Anesth 1992; 6: 554–67.
Ochiai Y, Morita S, Tanone Y, Kawachi Y, Tominaga R, Yasui H. Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations. J Thorac Cardiovasc Surg 1998: 116: 139–47.
Ferraris VA, Klingman R, Bufo A, Saifi J. Cardiopulmonary bypass. Curr Opin Cardiol 1991; 6: 227–34.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanoue, Y., Morita, S., Nagano, I. et al. Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation. Jpn J Thorac Caridovasc Surg 49, 607–613 (2001). https://doi.org/10.1007/BF02916224
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02916224